Hastings Center Report 40 (5):16-18 (2010)
The phrase "personalized medicine" has a built-in positive spin. Simple genetic tests can sometimes predict whether a particular individual will have a positive response to a particular drug or, alternatively, suffer costly and debilitating side effects. But little attention has been given to some challenging issues of justice raised by personalized medicine. How should we determine who would have a just claim to access particular treatments, especially very expensive ones? How effective do those treatments need to be?If there were a thick, bright line separating minimal responders from maximal responders, then we could allocate these treatments in a fair and cost-effective way. But there is no bright line. The ..
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
References found in this work BETA
No references found.
Citations of this work BETA
Between Hype and Hope: What is Really at Stake with Personalized Medicine?Camille Abettan - 2016 - Medicine, Health Care and Philosophy 19 (3):423-430.
Similar books and articles
Personalized Cancer Care in an Age of Anxiety.Susan Gilbert - 2010 - Hastings Center Report 40 (5):18-21.
Of Nanochips and Persons: Toward an Ethics of Diagnostic Technology in Personalized Medicine. [REVIEW]Sophie Pellé & Vanessa Nurock - 2012 - NanoEthics 6 (3):155-165.
Improving Health Care Outcomes Through Personalized Comparisons of Treatment Effectiveness Based on Electronic Health Records.Sharona Hoffman & Andy Podgurski - 2011 - Journal of Law, Medicine & Ethics 39 (3):425-436.
Should Direct-to-Consumer Personalized Genomic Medicine Remain Unregulated?: A Rebuttal of the Defenses.Sean A. Valles - 2012 - Perspectives in Biology and Medicine 55 (2):250-265.
Group-Based and Personalized Care in an Age of Genomic and Evidence-Based Medicine: A Reappraisal.Koffi N. Maglo - 2012 - Perspectives in Biology and Medicine 55 (1):137-154.
Re-Examining the Gene in Personalized Genomics.Jordan Bartol - 2013 - Science and Education 22 (10):2529-2546.
Ethical Dimensions of Disparities in Depression Research and Treatment in the Pharmacogenomic Era.Lisa S. Parker & Valerie B. Satkoske - 2012 - Journal of Law, Medicine & Ethics 40 (4):886-903.
Swabbing Students: Should Universities Be Allowed to Facilitate Educational DNA Testing?Shawneequa L. Callier - 2012 - American Journal of Bioethics 12 (4):32-40.
The Use of Personalized Medicine for Patient Selection for Renal Transplantation: Physicians' Views on the Clinical and Ethical Implications.Marianne Dion-Labrie, Marie-Chantal Fortin, Marie-Josée Hébert & Hubert Doucet - 2010 - BMC Medical Ethics 11 (1):5-.
The Prospects for Personalized Medicine.Shara Yurkiewicz - 2010 - Hastings Center Report 40 (5):14-16.
Where Should We Draw the Line Between Quality of Care and Other Ethical Concerns Related to Medical Registries and Biobanks?Mats Hansson - 2012 - Theoretical Medicine and Bioethics 33 (4):313-323.
What Should We Do When Participants Report Dangerous Drinking? The Impact of Personalized Letters Versus General Pamphlets as a Function of Sex and Controlled Orientation.Clayton Neighbors, Eric R. Pedersen, Debra Kaysen, Magdalena Kulesza & Theresa Walter - 2011 - Ethics and Behavior 22 (1):1 - 15.
Public Financing of Pain Management: Leaky Umbrellas and Ragged Safety Nets.Timothy S. Jost - 1998 - Journal of Law, Medicine & Ethics 26 (4):290-307.
A Sustainable Medicine: Lessons From the Old Order Amish. [REVIEW]Jennifer Girod - 2002 - Journal of Medical Humanities 23 (1):31-42.
Added to index2010-09-29
Total downloads27 ( #187,370 of 2,158,808 )
Recent downloads (6 months)2 ( #193,668 of 2,158,808 )
How can I increase my downloads?